Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

DR info

Clinical trials : 16 / Drugs : 17 - (DrugBank : 8) / Drug target genes : 5 - Drug target pathways : 79

Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)

CD19/bcma CAR T-cells
   Zhejiang University
      2021   Early Phase 1   NCT05263817   China
CT103A cells
   Tongji Hospital
      2020   Early Phase 1   NCT04561557   China
Cyclophosphamide
   Chiba University Hospital Department of Hematology
      2015   Phase 2   JPRN-UMIN000018385   Japan
   Sakaida Emiko
      2016   Phase 2   JPRN-jRCTs031180421   -
Cyclophosphamide and fludarabine
   Tongji Hospital
      2020   Early Phase 1   NCT04561557   China
Daratumumab injection
   University of Arkansas
      2020   Phase 2   NCT04396496   United States
Dexamethasone
   Chiba University Graduate School of Medicine
      2015   -   JPRN-UMIN000018660   Japan
   Mayo Clinic
      2016   Early Phase 1   NCT02921893   United States
   Qingdao Municipal Hospital
      2022   Phase 4   ChiCTR2200056637   China
G-CSF
   Chiba University Hospital Department of Hematology
      2015   Phase 2   JPRN-UMIN000018385   Japan
Ixazomib citrate
   Mayo Clinic
      2016   Early Phase 1   NCT02921893   United States
KQ-2003 CAR T-cells
   Novatim Immune Therapeutics (Zhejiang) Co., Ltd.
      2024   Phase 1   NCT06518876   China
Lenalidomide
   ISTITUTO CLINICO HUMANITAS
      2009   Phase 2   EUCTR2008-003202-33-IT   Italy
   Mayo Clinic
      2016   Early Phase 1   NCT02921893   United States
Lenalidomide and dexamethasone
   Istituto Clinico Humanitas
      2009   Phase 2   NCT00971685   Italy
   University Hospital, Limoges
      2012   Phase 2   NCT01639898   France
Lenalidomide+dexamethasone
   Chiba University
      2014   Phase 2   NCT02193698   Japan
Lenalidomide, dexamethasone
   Peking Union Medical College Hospital
      2014   Phase 2   NCT01816620   China
Lenograstim
   Sakaida Emiko
      2016   Phase 2   JPRN-jRCTs031180421   -
Questionnaire administration
   Mayo Clinic
      2016   Early Phase 1   NCT02921893   United States
Revlimid*21CPS 25MG
   ISTITUTO CLINICO HUMANITAS
      2009   Phase 2   EUCTR2008-003202-33-IT   Italy
Thalidomide
   Chiba University Graduate School of Medicine
      2015   -   JPRN-UMIN000018660   Japan
   J-POST Clinical Trial Office
      2012   Phase 3   JPRN-jRCT2091220084   Japan
      2010   Phase 2-3   JPRN-jRCT1091220046   Japan